(E)-2-(3-Chlorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

N-hydroxy7-[(pyridin-3-yl)carbamoyl]heptanimidic acid, 98%, 50mg

S-(Carboxymethyl)-L-Cysteine, 95.0%, 500g

2-(2-bromoethyl)-6-methylpyridine hydrobromide, 95.0%, 1g

(R)-1-phenylethanamine (2R,3R,4S)-4-(benzo[d][1,3]dioxol-5-yl)-1-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate, 98%, 100mg

(S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate, 98%, 10g

(1-Benzyl-pyrrolidin-2-yl)-methanol, 95.0%, 100g

D-glutammina, minimo 98,5%, per biochimica, 5 g, confezione in plastica.

N-(3-fluorobenzyl)formamide, 95.0%, 1g

10-(1H-imidazol-1-yl)decan-1-ol, 95+%, 1g

3-Iodo-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde, 95.0%, 1g

(S)-7-Hydroxy-5-methoxy-2-phenylchroman-4-one, 95.0%, 1g

2-Methyloctahydropyrrolo[3,4-c]pyrrole dihydrochloride, 95.0%, 100mg